LIVZON PHARMAC. GRP H YC1 (LP6) — Working Capital to Net Assets Ratio

LIVZON PHARMAC. GRP H YC1 (LP6) has a Working Capital to Net Assets ratio of 49.2% as of March 2026. Working capital of €7.67 Billion (current assets of €15.66 Billion minus current liabilities of €7.99 Billion) is measured against net assets of €15.58 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See LIVZON PHARMAC. GRP H YC1 net asset quality index to measure how much of total assets are equity-financed.